A carregar...
The Price Elasticity of Specialty Drug Use: Evidence from Cancer Patients in Medicare Part D
Specialty drugs can bring substantial benefits to patients with debilitating conditions, such as cancer, but their costs are very high. Insurers/payers have increased patient cost-sharing for specialty drugs to manage specialty drug spending. We utilized Medicare Part D plan formulary data to create...
Na minha lista:
| Publicado no: | Forum Health Econ Policy |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5877476/ https://ncbi.nlm.nih.gov/pubmed/29610565 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|